Goldman Sachs Group Inc - Mar 31, 2025 SCHEDULE 13G/A Report for SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share (SLXN)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0001 per share
Symbol: SLXN
Shares outstanding: 8.83M shares
Disclosed Ownership: 212K shares
Ownership: 2.4%
Form type: SCHEDULE 13G/A
Date filed: 5/13/2025, 11:36 AM
Date of event: Mar 31, 2025
Previous filing: Feb 10, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	2.4%	212K	0	212K	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	2.4%	212K	0	212K	Name: Sam Prashanth	Attorney-in-fact